The COVID-19 pandemic increased demands for respiratory disease testing to facilitate
treatment and limit transmission, demonstrating in the process that most existing test options …

From HIV and influenza to emerging pathogens like COVID-19, each new infectious disease
outbreak has highlighted the need for massively-scalable testing that can be performed …

Emerging and re-emerging infectious diseases pose global threats to human health.
Although several conventional diagnostic methods have been widely adopted in the clinic …

The COVID-19 pandemic greatly impacted the in vitro diagnostic market, leading to the
development of new technologies such as point-of-care testing (POCT), multiplex testing …

Development of small footprint, disposable, fast, and inexpensive devices for pathogen
detection in the field and clinic would benefit human and veterinary medicine by allowing …

Nucleic acid amplification-based diagnostics offer rapid, sensitive, and specific means for
detecting and monitoring the progression of infectious diseases. However, this method …

The field of molecular diagnostics has greatly decreased the time it takes to identify
infectious agents and to test their antimicrobial resistance. Portable devices are currently in …

The rapid detection and identification of infectious disease pathogens is a critical need for
healthcare in both developed and developing countries. As we gain more insight into the …

Rapid screening of infectious pathogens at the point-of-care (POC) is ideally low-cost,
portable, easy to use, and capable of multiplex detection with high sensitivity. However …

We developed an integrated PCR system that performs automated sample preparation and
fast polymerase chain reaction (PCR) for application in point-of care (POC) testing. This …